Credit: Getty Images Until semaglutide, weight loss of 15% ... treatment of obesity: STEP 1, the largest trial, compared semaglutide and LI with placebo and LI over 68 weeks.

The findings are being hailed as a promising step ... impressive weight-loss benefits, contains the active ingredient semaglutide, also found in diabetes drug Ozempic. The clinical trial, funded ...

A trial exploring ... the two doses of semaglutide were comparable, while around a third of patients treated with 7.2mg achieved more than 25% weight loss. "Results from STEP UP further strengthen ...

The submission is based on results from the phase 3 OASIS 4 trial, which studied a 25 mg dose of oral semaglutide in ... gains follow a volatile week in the weight loss drug sector.

Here is the chart again if you don't want to scroll up. Since the FDA announced in February 2025 that the shortage of semaglutide ... and clinical trials have shown better weight loss performance ...

On April 14, 2025, Pfizer® announced that it would scrap development of danuglipron as a once-daily oral GLP-1 treatment after a patient in a trial ... step forward for the weight loss and ...

Over 72 weeks, patients taking ... Novo Nordisk's STEP trial programme for once-weekly GLP-1 agonist Wegovy (semaglutide) revealed a reduction in body weight of around 12%, suggesting greater ...

In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide and tirzepatide have ... taking these medications for diabetes or weight loss report better sleep, but the trial ...

Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

In an interim analysis of an ongoing global trial, semaglutide resolved steatohepatitis in 63% of patients and reduced liver fibrosis, while also promoting weight loss ... 72 weeks as part of ...